Variant report
Variant | nsv968516 |
---|---|
Chromosome Location | chr8:88754170-88760731 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:88752001..88754722-chr8:88761392..88764098,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577382021 | chr8:88759600-88759601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538756371 | chr8:88759655-88759656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570204767 | chr8:88759694-88759695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7827917 | chr8:88759706-88759707 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs373914587 | chr8:88759726-88759727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530452130 | chr8:88759756-88759757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141765445 | chr8:88759768-88759769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542697630 | chr8:88759785-88759786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561320567 | chr8:88759836-88759837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs13439375 | chr8:88759846-88759847 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs544103199 | chr8:88759870-88759871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570471162 | chr8:88759907-88759908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12549708 | chr8:88759973-88759974 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs75333536 | chr8:88759981-88759982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532714800 | chr8:88759991-88759992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551505982 | chr8:88760034-88760035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560028881 | chr8:88760056-88760057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13256471 | chr8:88760083-88760084 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs548728161 | chr8:88760167-88760168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12549752 | chr8:88760185-88760186 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs146253687 | chr8:88760262-88760263 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141203424 | chr8:88760276-88760277 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181390537 | chr8:88760287-88760288 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538493903 | chr8:88760361-88760362 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555512035 | chr8:88760389-88760390 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117391161 | chr8:88760459-88760460 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536729109 | chr8:88760497-88760498 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116614360 | chr8:88760502-88760503 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576353350 | chr8:88760523-88760524 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72673112 | chr8:88760576-88760577 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs559249572 | chr8:88760598-88760599 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577601108 | chr8:88760643-88760644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186903036 | chr8:88760704-88760705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:88759600-88760200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr8:88759600-88761200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr8:88759800-88760000 | Enhancers | H1 Cell Line | embryonic stem cell |
4 | chr8:88759800-88760000 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr8:88759800-88760000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr8:88759800-88760000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr8:88759800-88760000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr8:88759800-88760600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr8:88759800-88760800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr8:88760000-88763000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr8:88760000-88766200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr8:88760000-88768000 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr8:88760000-88770600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr8:88760200-88760600 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
15 | chr8:88760200-88760800 | Enhancers | HUES64 Cell Line | embryonic stem cell |